During the past decade, University Hospital Germans Trias I Pujol conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Germans Trias I Pujol" #1 sponsor was "Germans Trias i Pujol Hospital" with 5 trials, followed by "Celgene" with 4 trials sponsored, "Baxter Healthcare Corporation" with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "Cidara Therapeutics Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Germans Trias I Pujol" #1 collaborator was "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 1 trials as a collaborator and "Instituto de Investigación Hospital Universitario La Paz" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Germans Trias I Pujol" are "Crohn Disease" (3 trials), "HIV" (2 trials), "HIV Infections" (2 trials), "Atrioventricular Block" (1 trials) and "Candidemia" (1 trials). Many other conditions were trialed in "University Hospital Germans Trias I Pujol" in a lesser frequency.

Most popular intervention types in "University Hospital Germans Trias I Pujol" are "Drug" (14 trials), "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "BGB-3111" (1 trials), "Caspofungin" (1 trials) and "Continue with the same antiretroviral regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Germans Trias I Pujol" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospital Germans Trias I Pujol". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in University Hospital Germans Trias I Pujol, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Germans Trias I Pujol, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".